Transfection with a dominant-negative inhibitor of monocyte chemoattractant protein-1 gene improves cardiac function after 6 hours of cold preservation

Circulation

Volumn 108, Issue 10 SUPPL., 2003, Pages

  Kajihara, Noriyoshi ^b   Morita, Shigeki ^a   Nishida, Takahiro ^b   Tatewaki, Hideki ^b   Eto, Masataka ^b   Egashira, Kensuke ^b   Yasui, Hisataka ^b  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

Cytokines; Gene therapy; Leukocytes; Reperfusion injury

Indexed keywords

CREATINE KINASE MB; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CRYOPRESERVATION; CYTOKINE PRODUCTION; ELECTROPORATION; GENETIC TRANSFECTION; HEART FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART OUTPUT; HEART PRESERVATION; HISTOPATHOLOGY; ISOLATED HEART; MONOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; RABBIT; REPERFUSION INJURY; SKELETAL MUSCLE;

ANIMALS; CELL MOVEMENT; CHEMOKINE CCL2; COLD; CREATINE KINASE; CREATINE KINASE, MB FORM; HEART; INTERLEUKIN-1; ISOENZYMES; MONOCYTES; MUTATION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; ORGAN PRESERVATION; RABBITS; TIME FACTORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT;

EID: 0042416948     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Entmann ML, Smith CW. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res. 1994;28:1301-1311.
2. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989;320:365-376.
3. Chandrasekar B, Colston JT, Geimer J, et al. Induction of nuclearκB but notκB: responsive cytokine expression during myocardial reperfusion injury after neutropenia. Free Rad Biol Med. 2000;28:1579-1588.
4. Formigli L, Manneschi LI, Nediani C, et al. Are macrophages involved in early myocardial reperfusion injury? Ann Thorac Surg. 2001;71:1596-1602.
5. Matsumori A, Furukawa Y, Hashimoto T, et al. Plasma level of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. J Mol Cell Cardiol. 1997;29:419-423.
6. Kumar AG, Ballantyne CM, Michael LH, et al. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation. 1997;95:693-700.
7. Egashira K, Zhao QW, Kataoka C, et al. Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after peri-arterial injury in mice and monkeys. 2002;90:1167-1172.
8. Egashira K, Koyanagi M, Kitamoto S, et al. Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis. FASEB J. 2000;14:1974-1978.
9. Ni W, Egashira K, Kitamoto S, et al. New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein e-knockout mice. Circulation. 2001;103:2096-2101.
10. Inoue S, Egashira K, Ni W, et al. Anti-monocyte chemoattractant prolein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein e-knockout mice. Circulation. 2002;106:2700-2706.
11. Usui M, Egashira K, Ohtani C, et al. Anti-monocyte chemoattractant protein-1 gene therapy inhibits restenotic changes (neointimal hyperplasia) after balloon injury in rats and monkeys. FASEB. 2002;16(5):1838-1840.
12. Zhang YJ, Rutledge BJ, Rollins BJ. Structure/activity analysis of human monocyte chemoattractant protein-1(MCP-1) by mutagenesis. J Biol Chem. 1994;269:15918-15924.
13. Zhang YJ and Rollins BJ. A dominant negative inhibitor indicates that monocyte chemoattractant protein-1 functions as a dimmer. Mol Cell Biol. 1995;15:4851-4855.
14. Nishida T, Morita S, Miyamoto K, et al. The effect of lazaroid (U74500A), a novel inhibitor of lipid peroxidation, on 24-hour heart preservation: a study based on a working model using cross-circulated blood perfused rabbit hearts. Transplantation. 1996;61:194-199.
15. Nishida T, Morita S, Miyamoto K, et al. Lazaroid (U74500) prevents vascular and myocardial dysfunction after 24-hour heart preservation: a study based on cross-circulation blood-perfused rabbit hearts. Circulation. 1996;94 (suppl II):II326-II331.
16. Yamashiro S, Takeya M, Kuratsu J, et al. Intradermal injection of monocyte chemoattractant protein-1 induces emigration and differentiation of blood monocytes in rat skin. Int Arch Allergy Immunol. 1998;115:15-23.
17. Glantz SA, Slinker BK. Primer of applied regression and analysis of variance. New York: McGraw-Hill; 1990.
18. Rollins BJ. Chemokines. Blood. 1997;90:909-928.
19. Ono K, Matsumori A, Furukawa Y, et al. Prevention of myocardial reperfusion injury in rats by an antibody against monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. Lab Invest. 1999;79:195-203.
20. Herskowits A, Choi S, Ansari AA, et al. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol. 1995;146:419-428.
21. Yokoyama T, Vaca L, Rossen RD, et al. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest. 1993;92:2303-2312.
22. Balligand JL, Ungureanu-Longrois D, Simmons WW, et al. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes: characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem. 1994;269:27580-27588.
23. Smart SJ, Casale TB. Pulmonary epitherial cells facilitate TNF-α-induced neutrophil chemotaxis. J Immunol. 1994;152:4087-4094.
24. Maloff BL, Shaw JE, Fox D. A chemotaxis assay using human polymorphonuclear leukocytes stimulated by IL-1. J Immunol Methods. 1988;112:145-146.
25. Riper GV, Siciliano S, Fischer PA, et al. Characterization and species distribution of high affinity GTP-coupled receptors for human Rantes and monocyte chemoattractant protein 1. J Exp Med. 1993;177:851-856.
26. Mori E, Komori K, Yamaoka T, et al. Essential role of monocyte chemoattractant proteine-1 in development of restenotic changes (neointimal hyperplasia and constructive remodeling) after balloon angioplasty in hypercholesterolemic rabbits. Circulation. 2002;105:2905-2910.